Literature DB >> 20156483

A near-infrared calibration method suitable for quantification of broadband data in humans.

Qiong Zhang1, Sathyanarayanan Srinivasan, Ying Wu, Siraj Natah, Jeff F Dunn.   

Abstract

Broadband near-infrared spectroscopy (bNIRS) is a powerful non-invasive technique for the measurement of hemoglobin. bNIRS systems are relatively simple to construct compared with many near-infrared instruments since they operate on the principle of continuous wave. The advantage of the broadband method is the capacity to model the spectra and to use "the second differential method" to quantify deoxyhemoglobin (HHb). An "anoxia pulse" method can be applied to quantify total haemoglobin (tHb) and tissue oxygen saturation (S(t)O(2)). A disadvantage is that this calibration method is not suitable for application in humans. In this study, we compared the "anoxia pulse" method with "graded hypoxia" method, which can be applied for human studies, to quantify tHb and S(t)O(2). The values obtained with the two methods were respectively (tHb=47.8+/-2.8 and 49.4+/-7.7 microM, mean+/-S.D., n=8) and (S(t)O(2)=72.8+/-3.7% and 73.2+/-5.7%, mean+/-S.D., n=8). There was no significant difference (p<0.05) between the two methods, indicating that the graded hypoxia method could be used for quantification of tHb and S(t)O(2) in human subjects. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156483     DOI: 10.1016/j.jneumeth.2010.01.037

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  2 in total

1.  Quantification of cytochrome c oxidase and tissue oxygenation using CW-NIRS in a mouse cerebral cortex.

Authors:  Mada Hashem; Ying Wu; Jeff F Dunn
Journal:  Biomed Opt Express       Date:  2021-11-17       Impact factor: 3.732

2.  Monitoring angiogenesis using a human compatible calibration for broadband near-infrared spectroscopy.

Authors:  Runze Yang; Qiong Zhang; Ying Wu; Jeff F Dunn
Journal:  J Biomed Opt       Date:  2013-01       Impact factor: 3.170

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.